← back to search

Yinghua Li

Qingdao Agricultural University ·
Area of research
Public Health, Environmental and Occupational Health · Materials Chemistry
Research interest
Research interests include Reproductive Biology and Fertility, Sperm and Testicular Function, Crystallization and Solubility Studies, and X-ray Diffraction in Crystallography.
h-index
25
citations
1,639
works
103
NIH funding
primary concept
email

Recent publications

Methyl Paraben Affects Porcine Oocyte Maturation Through Mitochondrial Dysfunction
Biomolecules 2024cited by 13position: middledoi
Bypassing the Heat Risk and Efficacy Limitations of Pulsed 630 nm LED Photobiomodulation Therapy for Anti-Primary Dysmenorrhea: A Prospective Randomized Cross-Over Trial
Photonics 2024cited by 10position: middledoi
Efficacy and Safety of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke
JAMA Network Open 2023cited by 32position: middledoi
Blue light photobiomodulation induced apoptosis by increasing ROS level and regulating SOCS3 and PTEN/PI3K/AKT pathway in osteosarcoma cells
Journal of Photochemistry and Photobiology B Biology 2023cited by 24position: middledoi
Efficacy and safety of an HDACi- and HMA-based protocol in adults with acute myeloid leukemia of intermediate- and adverse-risk categories: a retrospective study
Hematology 2023cited by 3position: lastdoi
Expression analysis, clinical significance and potential function of PLXNB2 in acute myeloid leukaemia
Molecular Biology Reports 2023cited by 1position: lastdoi
Exosomal MiR-4261 mediates calcium overload in RBCs by downregulating the expression of ATP2B4 in multiple myeloma
Frontiers in Oncology 2022cited by 5position: lastdoi
Histone deacetylase inhibitor chidamide regulates the Wnt/β-catenin pathway by MYCN/DKK3 in B-ALL
Investigational New Drugs 2021cited by 40position: lastdoi
A circular RNA derived from PLXNB2 as a valuable predictor of the prognosis of patients with acute myeloid leukaemia
Journal of Translational Medicine 2021cited by 21position: lastdoi
98P Camrelizumab as neoadjuvant, first- or later-line treatment for non-small cell lung cancer (NSCLC): A retrospective real-world study (CTONG2004)
Annals of Oncology 2021cited by 2position: middledoi
Chidamide, decitabine, cytarabine, aclarubicin, and granulocyte colony-stimulating factor (CDCAG) in patients with relapsed/refractory acute myeloid leukemia: a single-arm, phase 1/2 study
Clinical Epigenetics 2020cited by 38position: middledoi
Growth inhibition and suppression of the mTOR and Wnt/β‐catenin pathways in T‐acute lymphoblastic leukemia by rapamycin and <i>MYCN</i> depletion
Hematological Oncology 2020cited by 8position: lastdoi
Inhibition of CRY2 by STAT3/miRNA-7-5p Promotes Osteoblast Differentiation through Upregulation of CLOCK/BMAL1/P300 Expression
Molecular Therapy — Nucleic Acids 2019cited by 80position: middledoi
Integrating microRNA and mRNA expression in rapamycin-treated T-cell acute lymphoblastic leukemia
Pathology - Research and Practice 2019cited by 7position: lastdoi
&lt;p&gt;Assessment of the presence and anti-tumor potential of tumor-infiltrating lymphocytes in patients with acute myeloid leukemia&lt;/p&gt;
Cancer Management and Research 2019cited by 6position: middledoi
Circular RNA regulatory network reveals cell–cell crosstalk in acute myeloid leukemia extramedullary infiltration
Journal of Translational Medicine 2018cited by 62position: lastdoi
<i><scp>MYCN</scp></i> is a novel oncogenic target in adult B‐<scp>ALL</scp> that activates the Wnt/β‐catenin pathway by suppressing <i><scp>DKK</scp>3</i>
Journal of Cellular and Molecular Medicine 2018cited by 28position: lastdoi
Chidamide, Decitabine, Cytarabine, Aclarubicin, and Granulocyte Colony-Stimulating Factor (CDCAG) in Adults with Relapsed/Refractory Acute Myeloid Leukemia: Final Results from a Phase 1/2 Study
Blood 2018cited by 4position: middledoi
A novel TAL1/miR-149* axis accelerates tumor growth of human T cell acute lymphoblastic leukemia.
PubMed 2018cited by 2position: middle
Suppression of miR-708 inhibits the Wnt/β-catenin signaling pathway by activating DKK3 in adult B-all
Oncotarget 2017cited by 18position: middledoi
DNA methyltransferase 1 mediated aberrant methylation and silencing of SHP-1 gene in chronic myelogenous leukemia cells
Leukemia Research 2017cited by 14position: firstdoi
Integrating microRNA and mRNA expression profiles of acute promyelocytic leukemia cells to explore the occurrence mechanisms of differentiation syndrome
Oncotarget 2016cited by 5position: middledoi
miRNA-149* promotes cell proliferation and suppresses apoptosis by mediating JunB in T-cell acute lymphoblastic leukemia
Leukemia Research 2015cited by 62position: middledoi
Rapamycin restores p14, p15 and p57 expression and inhibits the mTOR/p70S6K pathway in acute lymphoblastic leukemia cells
International Journal of Hematology 2015cited by 11position: middledoi
The activation of c-Jun NH2-terminal kinase is required for dihydroartemisinin-induced autophagy in pancreatic cancer cells
Journal of Experimental & Clinical Cancer Research 2014cited by 72position: middledoi
[SHP-1 gene in the disease progression of chronic myeloid leukemia].
PubMed 2014cited by 0position: firstdoi
Long‐term efficacy and safety of arsenic trioxide for first‐line treatment of elderly patients with newly diagnosed acute promyelocytic leukemia
Cancer 2012cited by 48position: middledoi
Advances in the diagnosis and treatment of acute lymphoblastic leukemia in adolescents and young adults
International Journal of Pathology and Clinical Medicine 2012cited by 0position: first

Grants

No grants ingested yet.

Frequent collaborators

Lili Sun · Ministry of Education of the People's Republic of China12 papers (2015–2023)Shengjin Fan · Harbin Medical University11 papers (2012–2023)Zhibo Guo · Harbin Medical University9 papers (2018–2023)Leilei Lin · Harbin Medical University8 papers (2017–2023)Desheng Kong · Beijing Enterprises (China)8 papers (2017–2023)Yanqiu Zhao · Harbin Medical University7 papers (2015–2023)Huibo Li · Harbin Medical University6 papers (2015–2019)Sicheng Bian · Case Western Reserve University5 papers (2021–2023)Linlin Zhao · Shenyang University of Technology5 papers (2018–2023)Jianmin Luo · Hebei Medical University4 papers (2014–2020)Jin Zhou · Harbin Medical University3 papers (2015–2018)Chengfang Lv · Harbin Medical University3 papers (2012–2021)Yi-Gai Ma · Shanxi Medical University2 papers (2018–2020)Dan Guo · Kunming University of Science and Technology2 papers (2018–2021)Jin Zhou · Harbin Medical University2 papers (2015–2019)Jin Zhou · Harbin Medical University2 papers (2019–2021)Jin Zhou · Nanjing University of Chinese Medicine2 papers (2012–2016)Jiali Yang · Fudan University2 papers (2023–2024)Gang Cui · Nantong University2 papers (2015–2015)Guofeng Chen · Sun Yat-sen University Cancer Center2 papers (2018–2020)